Post-earnings recap
Reported
Thu, Feb 4, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 2.2% following the report, likely due to the lack of revenue details and guidance, leaving investors uncertain about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.26 | N/A | +5.69% |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized ongoing efforts to strengthen their market position.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and expanding our market presence.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—